01 January 1999
Disturbed cardiac rhythm as a manifestation of cardiotoxicity of individual doses of anthracycline cytostatics
Vladimir KovcinMed Sci Monit 1999; 5(1): CR32-39 :: ID: 505204
Abstract
Anthracyclines are cytotoxic drugs featuring cardiotoxicity as one of most prominent undesirable effects, which occurs in both its acute or cumulative from. The acute from of cardiotoxicity has been subject of much less concern although some sudden deaths have been reported during anthracycline administration (Wortman et al. Cancer 44; 1979). The present study involved 36 patients with soft tissue sarcomata, 28 with non-Hodgkin's lymphomas, 23 with nasopharyngeal carcinomas, 5 with carcinoma of the lungs, and 7 breast carcinoma patients (99 patients in total) who were treated with anthracyclines. Zorubicin was given to 40 patients, doxorubicin to 21, epidoxorubicin to 20, adn mitoxantron to 18 patients. Control groups were made of 29 patients who did not receive any anthracyclines and those who were treated with anthracyclines for the first time. In addition, as a third group, each patient was his/hers own control. All patients were subject to continuing ECG monitoring by using a Delmar Avionics Stratscan holter ECG monitor. In the course of intravenous infusion of anthracyclines, irregularities of heartbeat occurred in the form of sinus tachycardia and atrial (AEBs) and ventricular ectopic beats (VEBs). In relation to the control, the number of VEBs increased to level III of the Lown's scale while administering zorubicin, and then receded after the infusion. The number of AEBs remained steady or even increased for a certain while after administration of the drug. These irregularities were most prominent during the first administration of anthracycline. However, all registered changes are reversible and neither make a hindrance to therapy, nor necessitate cessation of anthracycline administration. A sporadic occurrence of VEBs at level III according to the Lown's scale point out to a possible occurrence of more severe rhythm disorders.
Keywords: doses, mode of administration, Holter-ECG, cardiotoxicity, Anthracyclines
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
06 Mar 2024 : Clinical Research
Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan ...Med Sci Monit In Press; DOI: 10.12659/MSM.943884
08 Mar 2024 : Clinical Research
Evaluation of Foot Structure in Preschool Children Based on Body MassMed Sci Monit In Press; DOI: 10.12659/MSM.943765
15 Apr 2024 : Laboratory Research
The Role of Copper-Induced M2 Macrophage Polarization in Protecting Cartilage Matrix in OsteoarthritisMed Sci Monit In Press; DOI: 10.12659/MSM.943738
07 Mar 2024 : Clinical Research
Knowledge of and Attitudes Toward Clinical Trials: A Questionnaire-Based Study of 179 Male Third- and Fourt...Med Sci Monit In Press; DOI: 10.12659/MSM.943468
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952